Gaviscon<sup>® </sup>vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial

Gaviscon<sup>® </sup>vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial

<p>Abstract</p> <p>Background</p> <p>Medical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon<sup>®</sup>, 4 × 10 mL/day) and omepraz...

Full description

Bibliographic Details
Main Authors: Pouchain Denis, Bigard Marc-André, Liard François, Childs Marc, Decaudin Annick, McVey Donna
Format: Article
Language:English
Published: BMC 2012-02-01
Series:BMC Gastroenterology
Subjects:
Alginate
Gastroesophageal reflux disease (GERD)
General practice
Omeprazole
Randomised controlled trial
Online Access:http://www.biomedcentral.com/1471-230X/12/18

Internet

http://www.biomedcentral.com/1471-230X/12/18

Similar Items